Standout Papers

Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database 2023 2026 202481
  1. Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database (2023)
    Daniel S. Peiffer, Fangyuan Zhao et al. JAMA Oncology

Immediate Impact

2 from Science/Nature 71 standout
Sub-graph 1 of 25

Citing Papers

Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization
2025 Standout
Pyridinium Rotor Strategy toward a Robust Photothermal Agent for STING Activation and Multimodal Image-Guided Immunotherapy for Triple-Negative Breast Cancer
2025 Standout
1 intermediate paper

Works of Daniel S. Peiffer being referenced

FOXO3, estrogen receptor alpha, and androgen receptor impact tumor growth rate and infiltration of dendritic cell subsets differentially between male and female mice
2017

Author Peers

Author Last Decade Papers Cites
Daniel S. Peiffer 239 170 92 111 15 538
Floriana Centritto 266 135 70 76 11 610
Makoto Sasaki 206 105 58 121 20 569
Tobias Hahn 276 157 117 70 19 503
Ling Gao 284 78 99 50 26 633
Amy L. Silvers 357 131 62 120 10 599
J. Wahler 214 182 57 77 15 495
Krista LaPerle 190 124 77 41 8 492
Thomas S. Frank 194 202 30 64 29 624
Gregory Harrison 237 96 54 70 14 550
Helena Cirenajwis 369 307 67 154 14 637

All Works

Loading papers...

Rankless by CCL
2026